Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar pro9185 (90.59) Submitted: 1/20/2008 8:12:19 PM : Outperform Start Price: $5.73 TRIB Score: +86.51

extremely undervalued.

Featured Broker Partners


Advertisement